Template:ID-FDAPregnancyCategories: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) (Created page with "==FDA Pregnancy Categories== {| class="wikitable sortable" width=50% ! Antimicrobial Agent ! Pregnancy Category ! Drug Class |- | Penicillins ||B||Antibacterial agents |- |...") |
Gerald Chi- (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
{| class="wikitable sortable" width=50% | {| class="wikitable sortable" width=50% | ||
! Antimicrobial Agent | ! Antimicrobial Agent | ||
Revision as of 05:00, 29 May 2015
| Antimicrobial Agent | Pregnancy Category | Drug Class |
|---|---|---|
| Penicillins | B | Antibacterial agents |
| Beta lactam/Beta lactam inhibitor | B | Antibacterial agents |
| Cephalosporins | B | Antibacterial agents |
| Aztreonam | B | Antibacterial agents |
| Meropenem | B | Antibacterial agents |
| Ertapenem | B | Antibacterial agents |
| Doripenem | B | Antibacterial agents |
| Clindamycin | B | Antibacterial agents |
| Daptomycin | B | Antibacterial agents |
| Fosfomycin | B | Antibacterial agents |
| Erythromycin | B | Antibacterial agents |
| Azithromycin | B | Antibacterial agents |
| Metronidazole | B | Antibacterial agents |
| Nitrofurantoin | B | Antibacterial agents |
| Imipenem/Cilastatin | C | Antibacterial agents |
| Chloramphenicol | C | Antibacterial agents |
| Ciprofloxacin | C | Antibacterial agents |
| Ofloxacin | C | Antibacterial agents |
| Levofloxacin | C | Antibacterial agents |
| Gatifloxacin | C | Antibacterial agents |
| Gemifloxacin | C | Antibacterial agents |
| Moxifloxacin | C | Antibacterial agents |
| Colistin | C | Antibacterial agents |
| Linezolid | C | Antibacterial agents |
| Clarithromycin | C | Antibacterial agents |
| Rifaximin | C | Antibacterial agents |
| Sulfonamides/Trimethoprim | C | Antibacterial agents |
| Telavancin | C | Antibacterial agents |
| Telithromycin | C | Antibacterial agents |
| Tinidazole | C | Antibacterial agents |
| Vancomycin | C | Antibacterial agents |
| Amikacin | D | Antibacterial agents |
| Gentamicin | D | Antibacterial agents |
| Isepamicin | D | Antibacterial agents |
| Netilmicin | D | Antibacterial agents |
| Streptomycin | D | Antibacterial agents |
| Tobramycin | D | Antibacterial agents |
| Tetracyclines | D | Antibacterial agents |
| Tigecycline | D | Antibacterial agents |
| Rifabutin | B | Antimycobacterial agents |
| Capreomycin | C | Antimycobacterial agents |
| Dapsone | C | Antimycobacterial agents |
| Isoniazid | C | Antimycobacterial agents |
| Pyrazinamide | C | Antimycobacterial agents |
| Rifampin | C | Antimycobacterial agents |
| Quinine | X | Antimycobacterial agents |
| Thalidomide | X | Antimycobacterial agents |
| Amphotericin B | B | Antifungal agents |
| Anidulafungin | C | Antifungal agents |
| Caspofungin | C | Antifungal agents |
| Fluconazole | C | Antifungal agents |
| Itraconazole | C | Antifungal agents |
| Ketoconazole | C | Antifungal agents |
| Flucytosine | C | Antifungal agents |
| Micafungin | C | Antifungal agents |
| Posaconazole | C | Antifungal agents |
| Terbinafine | B | Antifungal agents |
| Voriconazole | D | Antifungal agents |
| Nitazoxanide | B | Antiparasitic agents |
| Praziquantel | B | Antiparasitic agents |
| Albendazole | C | Antiparasitic agents |
| Mebendazole | C | Antiparasitic agents |
| Artemether | C | Antiparasitic agents |
| Lumefantrine | C | Antiparasitic agents |
| Atovaquone | C | Antiparasitic agents |
| Proguanil | C | Antiparasitic agents |
| Chloroquine | C | Antiparasitic agents |
| Eflornithine | C | Antiparasitic agents |
| Ivermectin | C | Antiparasitic agents |
| Mefloquine | C | Antiparasitic agents |
| Pentamidine | C | Antiparasitic agents |
| Pyrimethamine | C | Antiparasitic agents |
| Quinidine | C | Antiparasitic agents |
| Miltefosine | X | Antiparasitic agents |
| Acyclovir | B | Antiviral agents |
| Atazanavir | B | Antiviral agents |
| Darunavir | B | Antiviral agents |
| Didanosine | B | Antiviral agents |
| Emtricitabine | B | Antiviral agents |
| Enfuvirtide | B | Antiviral agents |
| Etravirine | B | Antiviral agents |
| Famciclovir | B | Antiviral agents |
| Maraviroc | B | Antiviral agents |
| Nelfinavir | B | Antiviral agents |
| Ritonavir | B | Antiviral agents |
| Saquinavir | B | Antiviral agents |
| Telbivudine | B | Antiviral agents |
| Tenofovir | B | Antiviral agents |
| Valacyclovir | B | Antiviral agents |
| Abacavir | C | Antiviral agents |
| Adefovir | C | Antiviral agents |
| Amantadine | C | Antiviral agents |
| Cidofovir | C | Antiviral agents |
| Delavirdine | C | Antiviral agents |
| Entecavir | C | Antiviral agents |
| Fosamprenavir | C | Antiviral agents |
| Foscarnet | C | Antiviral agents |
| Ganciclovir | C | Antiviral agents |
| Indinavir | C | Antiviral agents |
| Interferons | C | Antiviral agents |
| Lamivudine | C | Antiviral agents |
| Lopinavir | C | Antiviral agents |
| Ritonavir | C | Antiviral agents |
| Nevirapine | C | Antiviral agents |
| Oseltamivir | C | Antiviral agents |
| Raltegravir | C | Antiviral agents |
| Rimantadine | C | Antiviral agents |
| Stavudine | C | Antiviral agents |
| Tipranavir | C | Antiviral agents |
| Valganciclovir | C | Antiviral agents |
| Zalcitabine | C | Antiviral agents |
| Zanamivir | C | Antiviral agents |
| Zidovudine | C | Antiviral agents |
| Efavirenz | D | Antiviral agents |
| Ribavirin | X | Antiviral agents |
| Category | Definition |
| A | Adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in the first trimester of pregnancy |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women |
| C | Animal reproduction studies have shown an adverse effect on the fetus, if there are no adequate and well-controlled studies in humans, and if the benefits from the use of the drug in pregnant women may be acceptable despite its potential risks |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but the potential benefits from the use of the drug in pregnant women may be acceptable despite its potential risks |
| X | Studies in animals or humans have demonstrated fetal abnormalities or if there is positive evidence of fetal risk based on adverse reaction reports from investigational or marketing experience, or both, and the risk of the use of the drug in a pregnant woman clearly outweighs any possible benefit |